Abstract

Aims Because cancer is the leading cause of death worldwide, finding a better way to treat it seems essential. Doxorubicin is one of the most common drugs in the treatment of cancer, which has many negative and toxic effects. Therefore, efforts to produce effective anticancer drugs through screening natural compounds, such as animal toxins continue. This study aimed to evaluate the effect of Naja naja oxiana snake venom in comparison with doxorubicin on the proliferation rate and concentration of malondialdehyde in the human cervical cancer cell line (HeLa) and fibroblast cells (HFF). Methods & Materials HeLa and normal fibroblast cancer cell lines were exposed to different concentrations of snake venom and doxorubicin for 24 and 48 hours. The amplification rate was determined using trypan blue staining and malondialdehyde (MDA) concentration was measured to evaluate the effects of oxidative stress. Data were analyzed using SPSS software, version 19. Findings The results showed that with increasing concentration and treatment time with snake venom and doxorubicin, the cell proliferation rate decreases, and MDA content increases. The highest decrease in proliferation rate and increase in MDA concentration were observed in the HeLa cancer cell line treated with 500 µg/mL of snake venom for 48 hours. Conclusion In comparison with doxorubicin, snake venom has a significant inhibitory effect on the HeLa cancer cell line with minimal effect on normal fibroblast cells.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.